162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin
Journal of Thoracic Oncology - United States
doi 10.1016/s1556-0864(16)30272-6
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Elsevier BV